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Abstract
The tenacious human parasitic helminth Strongyloides stercoralis is a significant health
problem worldwide. The current lack of a definitive diagnostic laboratory test to rule out this
infection necessitates designing more specific diagnostic methods. Fatty acid and retinol-
binding protein (FAR) plays a crucial role in the development and reproduction of nema-
todes. We generated a recombinant form of this protein and determined its applicability for
immunodiagnosis of S. stercoralis. The L3 form of S. stercoralis was harvested and used for
RNA extraction and cDNA synthesis. The coding sequence of S. stercoralis FAR (SsFAR)
was cloned into pET28a(+) vector, expressed in E. coli BL21 and purified. ELISA and immu-
noblotting were employed to determine the specificity and sensitivity of rSsFAR using a set
of defined sera. In addition, we analyzed the phylogenetic relationship of SsFAR with differ-
ent FAR sequences from other nematodes. The cloned SsFAR had an open reading frame
of 447 bp encoding 147 amino acids, with a deduced molecular mass of 19 kD. The SsFAR
amino acid sequence was 93% identical to FAR of S. ratti. For differential immunodiagnosis
of strongyloidiasis, rSsFAR exhibited 100% sensitivity and 97% specificity. However, cross-
reactivity with FAR proteins of other parasites, namely Toxocara canis and Echinococcus
granulosus, was noted. Our results provide a novel approach for immunodiagnosis of S.
stercoralis infections using rSsFAR with reliable sensitivity and specificity.
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Introduction
Strongyloidiasis, caused by the tenacious human parasitic helminth Strongyloides stercoralis, is
a significant health problem [1, 2]. The precise prevalence of strongyloidiasis is not clear, but it
is estimated to affect at least 370 million people worldwide [3]. Strongyloidiasis is endemic in
some part of Iran but depending on the diagnosis methods, different prevalence rates were
reported ranging from 0.03 to 42% [4–9].
This soil-transmitted nematode enters the host through exposed skin and consequently
migrates to the small intestine [10]. Among helminths affecting humans, S. stercoralis has a
unique property of auto-infection and is capable of propagating within the host [11–13].
Strongyloidiasis may remain undiagnosed and untreated for decades, and upon immune-sup-
pression can lead to hyperinfection, severe morbidity and mortality [14].
The detection rate of the infective L3 larval form (iL3) of S. stercoralis by conventional
methods is low. To achieve a higher sensitivity, examination of multiple samples is required
[15, 16]. Up to now, the definitive diagnosis of strongyloidiasis has been achieved by coprolo-
gical procedures. However, conventional microscopic methods may fail to determine the
infection, because in approximately 70% of the cases the parasite load is below the detection
limit and the larval output by the adult worms is irregular [2, 3, 17–19].
In recent years, immunodiagnostic methods, particularly enzyme-linked immuno-sorbent
assay (ELISA), were improved and are now regarded as the method of choice for evaluating a
number of different helminthiasis [3, 20–22]. For instance, the high immunogenicity of
cathepsins, which are found in large quantities in some helminths excretory and secretory (E/
S) products [23, 24], resulted in the development of specific diagnostic methods. In addition,
some of these antigens were also exploited as promising vaccine candidates [25–28]. However,
a major caveat for serological approaches in diagnosis of helminthiasis is the cross-reactivity
with several other soil-transmitted nematodes, including hookworm and Trichostrongylus spe-
cies [29, 30]. Consequently, diagnosis of strongyloidiasis requires more sensitive techniques,
especially in those patients who suffer from mild infections with scarce excretion of larvae and
also in immunocompromised individuals [17]. Therefore, identification, cloning and charac-
terization of novel recombinant immunogens, with reliable sensitivity and specificity, could
simplify some issues of the immunodiagnosis in this field.
Usually, proteins which are applied in immunodiagnostic studies are abundantly expressed
and could be easily purified. In addition, high immunogenicity could potentially be translated
into protective immunity. Several small proteins which demonstrate the mentioned character-
istics, including fatty acid binding (FAB) and fatty acid and retinol-binding (FAR) proteins are
expressed at the surface of nematodes and are believed to be critical for helminth survival [31,
32]. Fatty acids are essential for lipid biosynthesis, neurological processes and cuticle assembly
of parasites [33, 34]. Moreover, it was previously observed that FAB is abundant in the fluid
surrounding the embryo in eggs and might be essential in nutrient acquisition and mainte-
nance of the eggshell of the developing larvae; thus FAB is regarded as a crucial molecule in
larva embryogenesis [35]. FAR also participates in intracellular and intercellular lipid signaling
and plays role in host defense mechanisms and pathogenesis of nematodes [25, 36–42]. More-
over, FAR has been shown to be suitable for immunodiagnosis and has confirmed good
potency in experimental vaccinology [25, 43]. Basavaraju et al. showed that Ancylostoma cani-
num FAR might enhance the infectivity of the parasite by reducing the available retinol mole-
cules that would be necessary for repairing damaged tissues during hookworm attachment
[36]. The 14-kDa FAB protein of Schistosoma mansoni (Sm14) has been proposed as a vaccine
candidate against S. mansoni infections in human and Fasciola hepatica against cattle and
sheep [44, 45].
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Characterization of the FAB or FAR proteins of S. stercoralis could help in understanding
their role in the pathogenesis of the infective form of this parasite. In this study, we generated a
recombinant version of FAR protein from the L3 stage of S. stercoralis (rSsFAR) and deter-
mined its immunogenicity and usefulness in the immunodiagnosis of strongyloidiasis.
Materials and methods
Ethics statement
The applied research protocols were approved by the Ethics Committee of Iran University of
Medical Sciences (code number IR.IUMS.REC 1395–9221577205). All participants were adult
and informed consent was obtained from each patient or control before participating in the
study or sample donation. Strongyloides stercoralis infected patients’ serum and stool samples
were collected from endemic areas including Mazandaran, Guilan and Khuzestan provinces of
Iran and anonymized before including in the study.
Isolation of parasites
Stool samples from microscopically confirmed S. stercoralis infected patients were cultivated
on nutrient agar plates at 25˚C. After three to four days of incubation, L3 larvae were observed
on the surface of the plates. After microscopic examination and observation of the active
movement and consequently the survival of the filariform larvae, the larvae were harvested
and washed several times with ice-cold phosphate buffered saline (PBS) to decrease bacterial
contamination [46].
Serum samples
A total of 113 serum samples were collected and categorized into one of following groups:
group A included 33 serum samples from individuals who were diagnosed with obvious S. ster-
coralis infection by stool examination. These samples were regarded as positive and used for
detection of specific antibodies; group B was composed of 40 serum samples from individuals
who were diagnosed as having other parasitic disease including hydatidosis (N = 14), toxocar-
iasis (N = 9), fasciolosis (N = 5), visceral leishmaniasis (N = 8), giardiasis (N = 3) and trichos-
trongyloidiasis (N = 1). These samples were applied to assess serological cross-reactivity.
Group C included 40 sera from individuals with no history of parasitic disease. These samples
were regarded as negative controls.
Cloning, expression and purification of rSsFAR
Total RNA was extracted from the iL3 form of S. stercoralis using Trizol reagent (Invitrogen,
Carlsbad, CA, USA), according to the manufacturer’s instructions with some modifications. In
brief, Trizol was added to the parasite pellet and the mixture was frozen and thawed several
times, and ground with a pestle and mortar to crush the larvae. The homogenate was centri-
fuged at 13,000 x g for 10 min and the supernatant was collected and used for RNA extraction.
The quality and quantity of the extracted RNA was evaluated by agarose gel electrophoresis
and Nanodrop spectrophotometry (Thermo Scientific, USA), respectively. Complementary
DNA (cDNA) synthesis was done using oligo (dT) primers using a commercial kit (Biofact,
South Korea) and the quality of the cDNA was checked by beta actin specific primers.
Since the nucleotide sequence of S. stercoralis FAR was unknown, we used the S. ratti FAR
sequence (GenBank accession number of CEF68179.1) for primer design through aligning the
coding sequence of S. ratti FAR with other available FAR sequences. The cDNA encoding the
full-length sequence of SsFAR was amplified by PCR, using specific forward primer (50
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ATA GGA TCC TCA GAT GAC TTA TTA GAA TCT 30) and reverse primer (50
ATA CTC GAG AAG TGG TAC CGG AAG GTG 30).Notably, the underlined sequences
indicate BamHI and XhoI restriction enzyme cutting sites, respectively. The PCR product was
cloned into the pTG19-T/A vector (Vivantis, Malaysia) and sequenced. White colonies harbor-
ing the target construct was selected for enzymatic digestion. The vector was digested with
BamHI and XhoI (Jena Bioscience, Jena, Germany) and the insert was ligated into the pET28a
(+) expression vector (Novagen, USA), and was used for transformation of E. coli DH5α. The
desired plasmid was purified by a commercial plasmid purification kit (Yekta Tajhiz Azma,
Tehran, Iran) and transformed into E. coli BL21(DE3) for optimal expression of recombinant
sSFAR (rSsFAR). The bacterial cells were grown in LB medium containing 50 μg/ml kanamy-
cin (Biosynth AG, Switzerland) at 37˚C to reach OD600 = 0.6. Finally, recombinant protein
expression was triggered by addition of 1 mM isopropyl-thiogalactoside (IPTG, Sigma, USA)
and incubation of the bacterial suspension for 4–6 hours at 37˚C. Subsequently, the bacterial
cells were harvested by centrifugation and following cell lysis, rSs FAR was purified using a Hi-
Trap chelating Sepharose column (Ni-NTA agarose, Qiagen, Hilden, Germany) [47].
SDS-PAGE and Western blotting
The quality of the purified rSsFAR was assessed by SDS-PAGE using 15% polyacrylamide gels,
followed by transfer to polyvinylidene difluoride (PVDF) membranes and immunoblotting
with anti-His-tagged antibody (Sigma-Aldrich, Saint Louis, USA) or with patients’ sera. In
brief, the transfer was done by semidry blotting (PeQLab, Belgium), and the membranes were
cut into strips and blocked with 5% skimmed milk in PBS overnight at 4˚C by constant shak-
ing on a rocker. After washing with PBS containing 0.05% Tween 20 (PBST), strips were incu-
bated with horseradish peroxidase (HRP)-conjugated anti-His-tag antibody (1:2000 dilution
in BSA 1%) or with patients’ sera diluted 1:100 in 1% BSA, for 2 h at room temperature (RT).
Subsequently, the membranes were washed three times, for a total of 15 min in PBST. The
anti-His-tag-reactive bands were visualized by diaminobenzidine (DAB) substrate (Roche,
USA). Strips that were incubated with the patients’ sera were extensively washed and incubated
with HRP-conjugated sheep anti-human IgG (Sina Biotech, Iran, 1:2000 dilution) for 1 h at
RT. Finally, the immunoreactivity of the specific antibodies in patient samples were visualized
as described above.
Optimization of SsFAR-specific ELISA
The titer of the specific antibody in patient sera against the purified protein was analyzed by an
indirect ELISA developed in-house. The 96-well microtiter plates (Nunc, Denmark) were
coated overnight at 4˚C with 2.5 μg/ml of rSsFAR solubilized in 0.2 M bicarbonate buffer pH
9.6. Subsequently, the wells were washed three times with PBST and blocked with 2% BSA/
PBST (2h in 37˚C). Patient sera (1:100 diluted) were added 100 μl/well and the plates incu-
bated for 2 hours at 37˚C. After four washes with PBST, 100 μl of HRP-conjugated sheep anti-
human antibody, diluted 1:1000, were added to the wells (Sina Biotech, Iran). Following 1 h
incubation at 37˚C the wells were washed four times with PBST and then 100 μl of tetra-
methyl-benzidine (TMB) substrate was dispensed into each well. The reaction was stopped
after 15 min by addition of 100 μl of 2N H2SO4 and the optical density (OD) was read by an
ELISA reader (BioHit, Helsinki, Finland) at 450 nm versus 630 nm as reference filter.
DNA sequence analysis
The SsFAR-1 cDNA and deduced amino acid sequence was aligned with sequences from FAR
homologues of other helminths retrieved from GenBank, including S. ratti, Haemonchus
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contortus, Caenorhabditis elegans, C. briggsae, Onchocerca volvulus, Wucheria. bancrofti, Bru-
giya malayi, B. pahangi and Toxocara canis using online ClustalW (http://www.clustal.org/
clustal2/) and Multalin (http://multalin.toulouse.inra.fr/multalin/) softwares (S1 and S2 Files).
Overlapping contigs were edited at each consensus position through Sequencher Tmv.4.1.4
Software (Gene Codes Corporation). The distance between all sequences was calculated and
phylogenetic trees were constructed by maximum-likelihood in the Kimura two-parameter
model by the MEGA 5.05 software (Arizona State University, Tempe, USA).
Statistical methods
All data were analyzed using GraphPad Prism version 6.0. (GraphPad Software, CA, USA).
The optimum cut-off value for ELISA assay, with a 95% confidence interval (CI), was obtained
by receiver-operating characteristic (ROC) curve analysis. ANOVA was used to detect signifi-
cant differences between the experimental groups. P values lower than 0.05 were considered
statistically significant.
Results
Plate-agar cultivation of the feces from 33 patients with microscopically confirmed S. stercora-
lis infection showed that 28 patients suffered from hyper-infection, and this resulted in the
propagation of numerous L3 forms of the parasite, which were collected and used for protein
and RNA extraction.
Western blotting of the crude extract of the L3 form with the pooled sera from hyper-
infected patients confirmed intensive antibody reactivity of a native protein with an apparent
molecular weight of 16 kDa. Although, immunoblotting of the crude extract with individual
patient sera showed different patterns of immunoreactivity, all strips demonstrated reactivity
with a 16 kDa protein band.
RNA was successfully extracted and used for cloning of SsFAR. PCR amplification of the
target sequence yielded a single 447 bp band (Fig 1; PubMed Ac No: LC315684) which showed
92% identity with S. ratti FAR (PubMed Ac No: XM_024653954.1) as well as significant
homologies to FAR sequences from other nematodes (S1 File).
SDS-PAGE analysis of the purified rSsFAR revealed expression of a single 19 kDa protein
band, which was consistent with the predicted size. The immunoreactivity of the recombinant
protein was simultaneously confirmed by ELISA and Western blotting. By immunoblotting,
the pooled sera of the strongyloidiasis patients showed strong immunoreactivity with the
recombinant protein (Fig 2).
ROC analysis of the ELISA results confirmed that the area under curve (AUC) value was
0.99 and the cut-off value was 0.6. All S. stercoralis infected patient sera showed a high fre-
quency of reactivity with the expressed protein, resulting in a mean OD of the patients’ sera
that was significantly higher than controls (1.37±0.36 versus 0.33±0.12). The sensitivity and
specificity of the reaction was determined to be 100% and 97%, respectively (Fig 3A and S3
File).
The expressed rSsFAR protein showed no significant cross-reactivity with sera obtained
from healthy individuals; however, we observed immunoreactivity of this protein with sera of
patients with other parasitic disease (Table 1, Fig 3B and S4 File).
Alignment of the deduced FAR amino acid sequence with FAR homologues from other
nematodes revealed similarities ranging between 93% (S. ratti) and 29% (T. canis) (Fig 4 and
S2 File). For construction of the phylogenetic tree, Schistosoma japonicum FAR was used as an
outgroup (Fig 5).
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Discussion
In this study we cloned and characterized SsFAR protein from the iL3 stage of S. stercoralis.
SsFAR exhibited high similarity (93%) with FAR protein secreted from S. ratti, and was also
similar to a lower degree (29–40%) to FAR proteins of other nematodes.
Fig 1. Fatty acid and retinol-binding protein (FAR) gene fragments of Strongyloides stercoralis. Fatty acid and
retinol binding protein (FAR) sequence of infective larvae of Strongyloides stercoralis was amplified by conventional
PCR and following insertion in pTG19-T/A vector was rechecked. Lane 1: PCR product of the amplification of FAR
gene from the cDNA of infective larvae of S. stercoralis; Lane 2: PCR amplification of FAR gene which was inserted
into pTG19-T/A vector with M13-specific primers: Lane M: 100 bp DNA ladder (Cinnagen, Tehran, Iran).
https://doi.org/10.1371/journal.pone.0218895.g001
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Immunoblotting with crude S. stercoralis L3 extract showed that pooled sera from infected
patients exhibited considerable reactivity with a 16 kDa protein band. Thus, following the
cloning steps, the expression conditions were optimized to prepare an appropriate recombi-
nant antigen to achieve an acceptable sensitivity and specificity in the immunoassay.
The results of immunoblotting confirmed strong reactivity of rSsFAR with sera from stron-
gyloidiasis patients. Thus, rSsFAR was applied for immunodiagnosis of strongyloidiasis by
indirect ELISA. The sensitivity and specificity were 100% and 97% respectively, which is com-
monly regarded to be reliable value for immunological detection of parasitic infections. How-
ever, by ELISA, rSsFAR showed cross-reactivity with 2 out of 14 hydatidosis patient sera and
also cross-reacted with one out of 9 toxocariasis patient serum samples in ELISA.
Fig 2. SDS-PAGE and immunoblotting of the crude extract, as well as recombinant fatty acid and retinol-binding protein of Strongyloides stercoralis. Fatty acid
and retinol-binding protein (FAR) was expressed in a prokaryotic host and the immunoreactivity of the purified protein was analyzed by immunoblotting. A:
Strongyloides stercoralis FAR gene was cloned in pET28a(+) plasmid, transformed in E. coli BL21 and the expression of the rFAR protein was induced by 1mM IPTG
within four hours of incubation at 37˚C. The bacterial cells were lysed and following centrifugation the contents of the precipitated and the supernatant fractions was
analyzed by 15% SDS-PAGE gels for evaluation of the expression of the target protein. The slabs were stained with Coomassie brilliant blue G250. Lane M: Protein
molecular weight marker. Lane 1: Supernatant of the lysed bacterial cells showing overexpression of a 19 kDa recombinant protein; Lane 2: Precipitate of the lysed
bacterial cells, Lane 3: Purified rFAR. B: The crude extract from infective larvae of S. stercoralis and purified rFAR was immunoblotted with pooled sera from hyper-
infected strongyloidiasis patients, as well as toxoariasis and hydatidosis patients. Furthermore, anti-his-tagged antibody was used for characterization of the recombinant
protein. M: Protein molecular weight marker, Lane 1–2: Immunoblotting of the crude extract with pooled sera of five strongyloidiasis patients; 3: Immunoblotting of the
crude extract with polled sera of two hyper-infected patients; Lane 4: Immunoblotting of the crude extract with toxocariasis patients’; Lane 5: Immunoblotting of the
crude extract with pooled sera of hydatidosis patients; Lane 6: Immunoblotting of rFAR protein with anti-his-tagged antibody, Lane 7: Immunoblotting of rFAR protein
with pooled sera of strongyloidiasis patients.
https://doi.org/10.1371/journal.pone.0218895.g002
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Up to now, the potential role of FAR in S. stercoralis has not been assessed. There is evi-
dence that FAR proteins play a critical role in the development, reproduction and molting of
other parasitic and non-parasitic nematodes [41, 48, 49]. In addition, FAR proteins may sup-
press host defense mechanisms and help Onchocerca volvulus to damage the nearby tissues
[50]. Our findings are in concordance with previous studies that described FAR proteins as
major immunodominant antigens in several infections and point out to their role in the infec-
tivity of some parasites [36].
During the last decades, there was a great effort to produce recombinant immunogenic pro-
teins for application in immunodiagnosis of S. stercoralis. Many recombinant proteins showed
variable sensitivity and specificity, with limited applicability. Up to now, only few proteins
were found to be useful in immunodiagnosis of strongyloidiasis. For instance, S. stercoralis
Fig 3. Receiver-operating characteristic (ROC) curves and the Cross-reactivity of rFAR sera from patients with other parasitic diseases. A: The ROC curve was
plotted using optical density (OD) obtained in ELISA for 33 serum samples from S. stercoralis-infected patients and 40 healthy controls. The area under the curve (AUC)
for recombinant Fatty acid and retinol-binding protein (rFAR) was 0.99. B: Cross-reactivity of rFAR with antibodies against other parasitic diseases was determined by
indirect ELISA. Sera from some other parasitic diseases were examined with rFAR-coated ELISA plates and did not show considerable cross-reactivity.
https://doi.org/10.1371/journal.pone.0218895.g003
Table 1. Cross-reactivity of the sera of the patients with various parasitic diseases with recombinant fatty acid and retinol-binding protein (rFAR) of S. stercoralis.
Infection Tested sera (%) Mean±SD Positive IgG-ELISA
No. (%)
Hydatidosis 14 (35%) 0.41 ±0.17 2 (14.2%)
Toxocariasis 9 (22.5%) 0.19 ±0.08 1 (11.1%)
Fascioliasis 5 (12.5%) 0.47±0.07 0
Visceral leishmaniasis 8 (32%) 0.26±0.05 0
Giardiasis 3 (7.5%) 0.22±0.07 0
Trichostrongyloidiasis 1 (2.5%) 0.45±0.0 0
Total 40 3 (7.5%)
https://doi.org/10.1371/journal.pone.0218895.t001
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immmunoreactive antigen (SsIR) and a 31-kDa recombinant antigen of its iL3 form (NIE)
revealed high reliability. Ravi et al. demonstrated that coating of ELISA plates with NIE
resulted in seropositivity in 78.5% of the patients and 6.6% of the controls [51]. Recently, appli-
cation of luciferase immunoprecipitation system (NIE-LIPS) improved the sensitivity and
specificity of NIE-specific ELISA and gained good sensitivity (75–98%) and specificity (94–
100%) [20, 51–53]. Mounsey et al. utilized the recombinant NIE antigen for analysis of dried
blood spots and showed that this method has a good diagnostic performance with 85.7% sensi-
tivity and 88.9% specificity [54]. This method also elucidated comparable sensitivity and speci-
ficity to routine NIE-ELISA, thus, it seems that the collection of dried blood spots may be a
useful approach for seroprevalence screening of strongyloidiasis [54]. Rascoe et al. employed
NIE antigen in a standard ELISA and in a fluorescent bead-based assay (Luminex) to detect S.
stercoralis-specific IgG4. The sensitivity and specificity of this antigen in ELISA was 95% and
Fig 4. Multiple sequence alignment of fatty acid and retinol-binding protein (FAR) of S. stercoralis. Fatty acid and retinol-binding protein (FAR) of S. stercoralis and
other nematode including S. ratti (CEF70273.1), H. contortus (ACR48262.1, CDJ86883), C. elegans (CAA79616.1), C. briggsae (CAP27058.1), O. volvulus (AAC32662.1),
W. bancrofti (AAL33794.1, EJW81696.1), B. malayi (AAB08893.1), B. pahangi (AAL33793.1), T. canis (KHN88406.1) were analyzed by multiple sequence alignment
using NCBI protein database, online ClustalW (http://www.clustal.org/clustal2/) and Multalin (http://multalin.toulouse.inra.fr/multalin/) software.
https://doi.org/10.1371/journal.pone.0218895.g004
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93%, respectively; while, the sensitivity and specificity for Luminex assay was 93% and 95%,
respectively [55].
Arifin et al. succeeded in cloning and identification of Ss-1a protein from a S. stercoralis
cDNA library and demonstrated its potential role in diagnosis of strongyloidiasis. Moreover,
they concluded that Ss-1a has a high similarity with immunoglobulin-binding protein 1 of S.
ratti and reported 96% sensitivity and 93% specificity for this novel recombinant protein [56].
More recently, we applied recombinant 14-3-3 in ELISA systems to detect anti-S. stercoralis
IgG antibodies and found that the sensitivities of the 14-3-3-ELISA assays was 96% [57]. A
comparative analysis should be undertaken to evaluate the performance of rSsFAR-based
ELISA in comparison to other recombinant antigens. In this study, we fund that rSs-FAR is an
excellent recombinant protein for serodiagnosis of human strongyloidiasis. According to our
findings, rSs-FAR protein has a relatively higher sensitivity and specificity than other proteins
used to detect the IgG titer in the patients sera.
Furthermore, it seems that rSs-FAR may be also applied for immunoprophylactic purposes,
too; however, its effectiveness as a recombinant immunogen should be further investigated.
In this work, we encountered some problems such as low accessibility to enough number of
serum samples from other parasitic diseases for inclusion in ELISA; thus, we could not broadly
Fig 5. Phylogenetic tree of fatty acid and retinol-binding protein (FAR) of S. stercoralis with other nematodes. The phylogenetic tree was constructed using amino
acids sequences of S. ratti (CEF70273.1), H. contortus (ACR48262.1, CDJ86883), C. elegans (CAA79616.1), C. briggsae (CAP27058.1), O. volvulus (AAC32662.1), W.
bancrofti (AAL33794.1, EJW81696.1), B. malayi (AAB08893.1), B. pahangi (AAL33793.1), T. canis (KHN88406.1) obtained from NCBI protein database. The Neighbor-
joining phylogenetic tree rooted against the FAR protein sequences of the trematode Schistosoma japonicum was generated using MEGA 5 software (Arizona State
University, Tempe, USA).
https://doi.org/10.1371/journal.pone.0218895.g005
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investigate the cross-reactivity of S. stercoralis antigens with other parasites which demonstrate
similar symptoms. Hence, further evaluation of additional serum samples may provide more
reliable interpretation of the obtained results.
Conclusions
In conclusion, we cloned the cDNA coding for the fatty acid and retinol-binding protein of S.
stercoralis (SsFAR), obtained the full-length sequence, and expressed it as a recombinant anti-
gen (rSsFAR) in bacteria. We found that rSsFAR protein could be considered as an alternative
diagnostic tool in ELISA for the detection of S. stercoralis infections, with a sensitivity and
specificity of 100% and 97%, respectively. Finally, since SsFAR is an immunodominant anti-
gen, in addition to its possible applications in immunodiagnosis, it could be used in vaccinol-
ogy studies against S. stercoralis infections.
Supporting information
S1 File. Alignment of oligonucleotides. Alignment of oligonucleotide sequences of Fatty
acid and retinol-binding protein (FAR). Oligonucleotide sequences from Strongyloides and
other nematodes which were used for alignment and determination of their homology.
(TXT)
S2 File. Alignment of proteins. Alignment of protein sequences of Fatty acid and retinol-
binding protein (FAR). Protein sequences from Strongyloides species and other nematodes
which were used for alignment and determination of their homology.
(TXT)
S3 File. FAR-ROC Test. Receiver-operating characteristic (ROC) curves data for Fatty acid
and retinol-binding protein (FAR). Graph-Pad Prism software were applied to plot ROC
curve using ELISA optical density (OD) results of strongyloidiasis patients and healthy con-
trols.
(PZFX)
S4 File. Anova Test-Prism FAR. Anova test for cross-reactivity of Fatty acid and retinol-
binding protein (FAR). Graph-Pad Prism software were applied to evaluate the ELISA results




This research is a part of Ph. D thesis of the first author and was supported by grant no. 27828
from Iran University of Medical Sciences, Tehran, Iran. We express our sincere thanks to Pro-
fessor Abdolfattah Sarafnejad and Mr. Keyvan Majidi from Noor Referral Laboratory, Tehran,
Iran; and also to Mr. Ali Farzanegan from Guilan University of Medical Sciences for providing
us with some patient’s sera.
Author Contributions
Conceptualization: Ahmad Reza Meamar.
Data curation: Leila Masoori.
Formal analysis: Leila Masoori, Alireza Badirzadeh.
Application of FAR protein for immunodiagnosis of strongyloidiasis
PLOS ONE | https://doi.org/10.1371/journal.pone.0218895 July 22, 2019 11 / 15
Funding acquisition: Ahmad Reza Meamar.
Investigation: Leila Masoori, Ahmad Reza Meamar, Kobra Mokhtarian.
Methodology: Leila Masoori, Mojgan Bandehpour, Elham Razmjou, Kobra Mokhtarian, Alir-
eza Badirzadeh, Nahid Jalallou, Reza Falak.
Project administration: Ahmad Reza Meamar.
Resources: Ahmad Reza Meamar.




Writing – original draft: Leila Masoori, Mona Roozbehani, Reza Falak.
Writing – review & editing: Leila Masoori, Ahmad Reza Meamar, Mojgan Bandehpour,
Andrew Hemphill, Elham Razmjou, Nahid Jalallou, Lame Akhlaghi, Reza Falak.
References
1. Krolewiecki AJ, Lammie P, Jacobson J, Gabrielli A-F, Levecke B, Socias E, et al. A public health
response against Strongyloides stercoralis: time to look at soil-transmitted helminthiasis in full. PLoS
Negl Trop Dis. 2013; 7(5):e2165. https://doi.org/10.1371/journal.pntd.0002165 PMID: 23675541
2. Scha¨r F, Trostdorf U, Giardina F, Khieu V, Muth S, Marti H, et al. Strongyloides stercoralis: global distri-
bution and risk factors. PLoS Negl Trop Dis. 2013; 7(7):e2288. https://doi.org/10.1371/journal.pntd.
0002288 PMID: 23875033
3. Bisoffi Z, Buonfrate D, Montresor A, Requena-Me´ndez A, Muñoz J, Krolewiecki AJ, et al. Strongyloides
stercoralis: a plea for action. PLoS Negl Trop Dis. 2013; 7(5):e2214. https://doi.org/10.1371/journal.
pntd.0002214 PMID: 23675546
4. Nasiri V, Esmailnia K, Karim G, Nasir M, Akhavan O. Intestinal parasitic infections among inhabitants of
Karaj City, Tehran province, Iran in 2006–2008. The Korean journal of parasitology. 2009; 47(3):265.
https://doi.org/10.3347/kjp.2009.47.3.265 PMID: 19724700
5. Kia E, Mahmoudi M, Zahabiun F, Meamar A. An evaluation on the efficacy of agar plate culture for
detection of Strongyloides stercoralis. Iran J Parasitol. 2007; 2(1):29–34.
6. Badparva E, Nayebzadeh H, Barkhordari MH, Ezatpour B. Epidemiological study of strongyloides ster-
coralis with a comparative diagnostic approach, in lorestan, west of iran. Archives of Clinical Infectious
Diseases. 2014; 9(2).
7. Daryani A, Sharif M, Nasrolahei M, Khalilian A, Mohammadi A, Barzegar G. Epidemiological survey of
the prevalence of intestinal parasites among schoolchildren in Sari, northern Iran. Transactions of the
Royal Society of Tropical Medicine and Hygiene. 2012; 106(8):455–9. https://doi.org/10.1016/j.trstmh.
2012.05.010 PMID: 22703897
8. Shokri A, Sarasiabi KS, Teshnizi SH, Mahmoodi H. Prevalence of Strongyloides stercoralis and other
intestinal parasitic infections among mentally retarded residents in central institution of southern Iran.
Asian Pacific journal of tropical biomedicine. 2012; 2(2):88–91. https://doi.org/10.1016/S2221-1691(11)
60198-6 PMID: 23569874
9. Ashrafi K, Tahbaz A, Rahmati B. Strongyloides stercoralis: The most prevalent parasitic cause of eosin-
ophilia in Gilan Province, northern Iran. Iranian Journal of Parasitology. 2010; 5(3):40. PMID: 22347254
10. Streit A. Reproduction in Strongyloides (Nematoda): a life between sex and parthenogenesis. Parasitol-
ogy. 2008; 135(3):285–94. https://doi.org/10.1017/S003118200700399X PMID: 18076772
11. Vadlamudi RS, Chi DS, Krishnaswamy G. Intestinal strongyloidiasis and hyperinfection syndrome. Clin
Mol Allergy 2006; 4(1):1–13. https://doi.org/10.1186/1476-7961-4-8 PMID: 16734908
12. Keiser PB, Nutman TB. Strongyloides stercoralis in the immunocompromised population. Clin Microbiol
Rev. 2004; 17(1):208–17. https://doi.org/10.1128/CMR.17.1.208-217.2004 PMID: 14726461
Application of FAR protein for immunodiagnosis of strongyloidiasis
PLOS ONE | https://doi.org/10.1371/journal.pone.0218895 July 22, 2019 12 / 15
13. Concha R, Harrington W Jr, Rogers AI. Intestinal strongyloidiasis: recognition, management, and deter-
minants of outcome. J Clin Gastroenterol. 2005; 39(3):203–11. http://10.1097/01.mcg.0000152779.
68900.33. PubMed Central PMCID: PMCPMID: 15718861 PMID: 15718861
14. Olsen A, van Lieshout L, Marti H, Polderman T, Polman K, Steinmann P, et al. Strongyloidiasis–the
most neglected of the neglected tropical diseases? Trans R Soc Trop Med Hyg. 2009; 103(10):967–72.
https://doi.org/10.1016/j.trstmh.2009.02.013 PMID: 19328508
15. Marcos LA, Terashima A, DuPont HL, Gotuzzo E. Strongyloides hyperinfection syndrome: an emerging
global infectious disease. Trans R Soc Trop Med Hyg. 2008; 102(4):314–8. https://doi.org/10.1016/j.
trstmh.2008.01.020 PMID: 18321548
16. Verweij JJ, Canales M, Polman K, Ziem J, Brienen EA, Polderman AM, et al. Molecular diagnosis of
Strongyloides stercoralis in faecal samples using real-time PCR. Trans R Soc Trop Med Hyg. 2009; 103
(4):342–6. https://doi.org/10.1016/j.trstmh.2008.12.001 PMID: 19195671
17. Ericsson CD, Steffen R, Siddiqui AA, Berk SL. Diagnosis of Strongyloides stercoralis infection. Clin
Infect Dis. 2001; 33(7):1040–7. https://doi.org/10.1086/322707 PMID: 11528578
18. Rodrigues RM, de Oliveira MC, Sopelete MC, Silva DA, Campos DM, Taketomi EA, et al. IgG1, IgG4,
and IgE antibody responses in human strongyloidiasis by ELISA using Strongyloides ratti saline extract
as heterologous antigen. J Parasitol Res. 2007; 101(5):1209–14. https://doi.org/10.1007/s00436-007-
0602-z PMID: 17610082
19. Boonmars T, Khunkitti W, Sithithaworn P, Fujimaki Y. In vitro antiparasitic activity of extracts of Cardios-
permum halicacabum against third-stage larvae of Strongyloides stercoralis. J Parasitol Res. 2005; 97
(5):417–9. https://doi.org/10.1007/s00436-005-1470-z PMID: 16151739
20. Krolewiecki AJ, Ramanathan R, Fink V, McAuliffe I, Cajal SP, Won K, et al. Improved diagnosis of
Strongyloides stercoralis using recombinant antigen-based serologies in a community-wide study in
northern Argentina. Clin Vaccine Immunol. 2010; 17(10):1624–30. https://doi.org/10.1128/CVI.00259-
10 PMID: 20739501
21. Pak BJ, Vasquez-Camargo F, Kalinichenko E, Chiodini PL, Nutman TB, Tanowitz HB, et al. Develop-
ment of a rapid serological assay for the diagnosis of strongyloidiasis using a novel diffraction-based
biosensor technology. PLoS Negl Trop Dis. 2014; 8(8):e3002. https://doi.org/10.1371/journal.pntd.
0003002 PMID: 25102174
22. Siddiqui AA, Koenig NM, Sinensky M, Berk SL. Strongyloides stercoralis: identification of antigens in
natural human infections from endemic areas of the United States. J Parasitol Res. 1997; 83(7):655–8.
PubMed Central PMCID: PMCPMID: 9272553.
23. Teofanova D, Hristov P, Yoveva A, Radoslavov G. Native and Recombinant Fatty Acid Binding Protein
3 from Fasciola Hepatica as a Potential Antigen. Biotechnol Biotechnol Equip. 2012; 26(sup1):60–4.
https://doi.org/10.5504/50YRTIMB.2011.0011.
24. Mokhtarian K, Akhlaghi L, Mohammadi M, Meamar AR, Razmjou E, Khoshmirsafa M, et al. Evaluation
of anti-Cathepsin L1: a more reliable method for serodiagnosis of human fasciolosis. Trans R Soc Trop
Med Hyg. 2016; 110(9):542–50. https://doi.org/10.1093/trstmh/trw063 PMID: 27794095
25. Fairfax KC, Vermeire JJ, Harrison LM, Bungiro RD, Grant W, Husain SZ, et al. Characterisation of a
fatty acid and retinol binding protein orthologue from the hookworm Ancylostoma ceylanicum. Int J
Parasitol. 2009; 39(14):1561–71. https://doi.org/10.1016/j.ijpara.2009.06.005 PubMed Central PMCID:
PMCPMID: 19591834. PMID: 19591834
26. Rodpai R, Intapan PM, Thanchomnang T, Sanpool O, Janwan P, Laummaunwai P, et al. Strongyloides
stercoralis diagnostic polypeptides for human strongyloidiasis and their proteomic analysis. J Parasitol
Res. 2016; 115(10):4007–12. https://doi.org/10.1007/s00436-016-5170-7 PubMed Central PMCID:
PMCPMID: 27312043 PMID: 27312043
27. Marcilla A, Sotillo J, Perez-Garcia A, Igual-Adell R, Valero ML, Sa´nchez-Pino M, et al. Proteomic analy-
sis of Strongyloides stercoralis L3 larvae. Parasitology. 2010; 137(10):1577–83. PubMed Central
PMCID: PMCPMID: 27312043 https://doi.org/10.1017/S0031182010000314 PMID: 20388238
28. Minematsu T, Mimori T, Tanaka M, Tada I. The effect of fatty acids on the developmental direction of
Strongyloides ratti first-stage larvae. J Helminthol. 1989; 63(2):102–6. PubMed Central PMCID:
PMCPMID: 2738378. PMID: 2738378
29. Sudarshi S, Stu¨mpfle R, Armstrong M, Ellman T, Parton S, Krishnan P, et al. Clinical presentation and
diagnostic sensitivity of laboratory tests for Strongyloides stercoralis in travellers compared with immi-
grants in a non-endemic country. Trop Med Int Health. 2003; 8(8):728–32. PubMed Central PMCID:
PMCPMID: 12869094. PMID: 12869094
30. Wang L-f, Xu L, Luo S-q, Xie H, Chen W, Wu Z-d, et al. Diagnosis of Strongyloides stercoralis by mor-
phological characteristics combine with molecular biological methods. J Parasitol Res. 2017; 116
(4):1159–63. https://doi.org/10.1007/s00436-017-5389-y PubMed Central PMCID: PMCPMID:
28124134 PMID: 28124134
Application of FAR protein for immunodiagnosis of strongyloidiasis
PLOS ONE | https://doi.org/10.1371/journal.pone.0218895 July 22, 2019 13 / 15
31. Blaxter M, Page A, Rudin W, Maizels R. Nematode surface coats: actively evading immunity. Parasitol
Today. 1992; 8(7):243–7. PubMed Central PMCID: PMCPMID: 15463630. PMID: 15463630
32. Jones J, Reavy B, Smant G, Prior A. Glutathione peroxidases of the potato cyst nematode Globodera
rostochiensis. Gene. 2004; 324:47–54. PubMed Central PMCID: PMCPMID: 14693370. https://doi.org/
10.1016/j.gene.2003.09.051 PMID: 14693370
33. Fairfax KC, Harrison LM, Cappello M. Molecular cloning and characterization of a nematode polyprotein
antigen/allergen from the human and animal hookworm Ancylostoma ceylanicum. Mol biochem parasit.
2014; 198(1):37–44. https://doi.org/10.1016/j.molbiopara.2014.11.005 PubMed Central PMCID:
PMCPMID: 25481749 PMID: 25481749
34. Lee D. Cuticle, moulting and exsheathment. The biology of nematodes: CRC Press 2002. p. 171–209
35. Iba´ñez-Shimabukuro M, Rey-Burusco MF, Cooper A, Kennedy MW, Co´rsico B, Smith BO. Resonance
assignment of As-p18, a fatty acid binding protein secreted by developing larvae of the parasitic nema-
tode Ascaris suum. Biomol NMR Assign. 2014; 8(1):33–6. https://doi.org/10.1007/s12104-012-9447-1
PubMed Central PMCID: PMCPMID: 23225165. PMID: 23225165
36. Basavaraju S, Zhan B, Kennedy MW, Liu Y, Hawdon J, Hotez PJ. Ac-FAR-1, a 20 kDa fatty acid-and
retinol-binding protein secreted by adult Ancylostoma caninum hookworms: gene transcription pattern,
ligand binding properties and structural characterisation. Mol Biochem Parasite. 2003; 126(1):63–71.
PubMed Central PMCID: PMCPMID: 12554085.
37. Garofalo A, Kennedy MW, Bradley JE. The FAR proteins of parasitic nematodes: their possible involve-
ment in the pathogenesis of infection and the use of Caenorhabditis elegans as a model system to eval-
uate their function. Med Microbiol Immunol. 2003; 192(1):47–52. https://doi.org/10.1007/s00430-002-
0158-6 PubMed Central PMCID: PMCPMID: 12592563. PMID: 12592563
38. Garofalo A, Kla¨ger SL, Rowlinson M-C, Nirmalan N, Klion A, Allen JE, et al. The FAR proteins of filarial
nematodes: secretion, glycosylation and lipid binding characteristics. Mol Biochem Parasitol. 2002; 122
(2):161–70. https://doi.org/10.1016/S0166-6851(02)00097-X PMID: 12106870
39. Kennedy MW, Garside LH, Goodrick LE, McDermott L, Brass A, Price NC, et al. The Ov20 protein of
the parasitic nematode Onchocerca volvulus A structurally novel class of small helix-rich retinol-binding
proteins. J Biol Chem. 1997; 272(47):29442–8. PubMed Central PMCID: PMCPMID: 9368002. https://
doi.org/10.1074/jbc.272.47.29442 PMID: 9368002
40. Bath JL, Robinson M, Kennedy MW, Agbasi C, Linz L, Maetzold E, et al. Identification of a secreted
fatty acid and retinol-binding protein (Hp-FAR-1) from Heligmosomoides polygyrus. J Nematol. 2009;
41(3):228–33. PubMed Central PMCID: PMCPMID: 22736819 PMID: 22736819
41. Prior A, Jones JT, Beauchamp J, Mcdermott L, Cooper A, Kennedy MW. A surface-associated retinol-
and fatty acid-binding protein (Gp-FAR-1) from the potato cyst nematode Globodera pallida: lipid bind-
ing activities, structural analysis and expression pattern. Biochem J. 2001; 356(2):387–94. PubMed
Central PMCID: PMCPMID: 11368765.
42. Franchini GR, Porfido JL, Shimabukuro MI, Burusco MFR, Belgamo JA, Smith BO, et al. The unusual
lipid binding proteins of parasitic helminths and their potential roles in parasitism and as therapeutic tar-
gets. Prostaglandins Leukot Essent Fatty Acids. 2015; 93:31–6. https://doi.org/10.1016/j.plefa.2014.08.
003 PubMed Central PMCID: PMCPMID: 25282399. PMID: 25282399
43. Burbelo PD, Leahy HP, Iadarola MJ, Nutman TB. A four-antigen mixture for rapid assessment of Onch-
ocerca volvulus infection. PLoS Negl Trop Dis. 2009; 3(5):e438. https://doi.org/10.1371/journal.pntd.
0000438.
44. Tendler M, Brito CA, Vilar MM, Serra-Freire N, Diogo CM, Almeida MS, et al. A Schistosoma mansoni
fatty acid-binding protein, Sm14, is the potential basis of a dual-purpose anti-helminth vaccine. Proc
Natl Acad Sci. 1996; 93(1):269–73. PubMed Central PMCID: PMCPMID: 8552619. https://doi.org/10.
1073/pnas.93.1.269 PMID: 8552619
45. Tendler M, Simpson AJ. The biotechnology-value chain: development of Sm14 as a schistosomiasis
vaccine. Acta tropica. 2008; 108(2–3):263–6. https://doi.org/10.1016/j.actatropica.2008.09.002
PubMed Central PMCID: PMCPMID: 18834847 PMID: 18834847
46. Meamar A, Rezaian M, Mohraz M, Hadighi R, Kia E. Strongyloides stercoralis hyper-infection syndrome
in HIV+/AIDS patients in Iran. Parasitol Res 2007; 101(3):663–5. https://doi.org/10.1007/s00436-007-
0531-x PubMed Central PMCID: PMCPMID: 17401580. PMID: 17401580
47. Falak R, Varasteh A, Ketabdar H, Sankian M. Expression of grape class IV chitinase in Spodoptera fru-
giperda (Sf9) insect cells. Allergol Immunopathol (Madr) 2014; 42(4):293–301. https://doi.org/10.1016/j.
aller.2012.11.004 PubMed Central PMCID: PMCPMID: 23481555 PMID: 23481555
48. Garofalo A, Rowlinson M-C, Ngwa A, Hughes JM, Kelly SM, Price NC, et al. The FAR protein family of
the nematode caenorhabditis elegans. Differential lipid properties, structural characteristics and devel-
opmental regulation. J Biol Chem. 2002. https://doi.org/10.1074/jbc.M206278200 PubMed Central
PMCID: PMCPMID: 12502713. PMID: 12502713
Application of FAR protein for immunodiagnosis of strongyloidiasis
PLOS ONE | https://doi.org/10.1371/journal.pone.0218895 July 22, 2019 14 / 15
49. Kuang L, Colgrave ML, Bagnall NH, Knox MR, Qian M, Wijffels G. The complexity of the secreted NPA
and FAR lipid-binding protein families of Haemonchus contortus revealed by an iterative proteomics–
bioinformatics approach. Mol Biochem Parasitol. 2009; 168(1):84–94. https://doi.org/10.1016/j.
molbiopara.2009.07.001 PubMed Central PMCID: PMCPMID: 19615410 PMID: 19615410
50. Tree TI, Gillespie AJ, Shepley KJ, Blaxter ML, Tuan RS, Bradley JE. Characterisation of an immunodo-
minant glycoprotein antigen of Onchocerca volvulus with homologues in other filarial nematodes and
Caenorhabditis elegans. Mol Biochem Parasitol. 1995; 69(2):185–95. PubMed Central PMCID:
PMCPMID: 7770083. PMID: 7770083
51. Ravi V, Ramachandran S, Thompson RW, Andersen JF, Neva FA. Characterization of a recombinant
immunodiagnostic antigen (NIE) from Strongyloides stercoralis L3-stage larvae. Mol Biochem Parasitol.
2002; 125(1–2):73–81. https://doi.org/10.1016/S0166-6851(02)00214-1 PMID: 12467975
52. Bisoffi Z, Buonfrate D, Sequi M, Mejia R, Cimino RO, Krolewiecki AJ, et al. Diagnostic accuracy of five
serologic tests for Strongyloides stercoralis infection. PLoS Negl Trop Dis. 2014; 8(1):e2640. https://doi.
org/10.1371/journal.pntd.0002640 PMID: 24427320
53. Ramanathan R, Burbelo PD, Groot S, Iadarola MJ, Neva FA, Nutman TB. A luciferase immunoprecipi-
tation systems assay enhances the sensitivity and specificity of diagnosis of Strongyloides stercoralis
infection. J Infect Dis. 2008; 198(3):444–51. https://doi.org/10.1086/589718 PubMed Central PMCID:
PMCPMID: 18558872. PMID: 18558872
54. Mounsey K, Kearns T, Rampton M, Llewellyn S, King M, Holt D, et al. Use of dried blood spots to define
antibody response to the Strongyloides stercoralis recombinant antigen NIE. Acta tropica. 2014;
138:78–82. https://doi.org/10.1016/j.actatropica.2014.07.007 PubMed Central PMCID: PMCPMID:
25051188. PMID: 25051188
55. Rascoe LN, Price C, Shin SH, McAuliffe I, Priest JW, Handali S. Development of Ss-NIE-1 recombinant
antigen based assays for immunodiagnosis of strongyloidiasis. PLoS Negl Trop Dis. 2015; 9(4):
e0003694. https://doi.org/10.1371/journal.pntd.0003694 PMID: 25860665
56. Arifin N, Yunus MH, Nolan TJ, Lok JB, Noordin R. Identification and Preliminary Evaluation of a Novel
Recombinant Protein for Serodiagnosis of Strongyloidiasis. Am J Trop Med Hyg. 2018; 98(4):1165–70.
https://doi.org/10.4269/ajtmh.17-0697 PubMed Central PMCID: PMCPMID: 29436335. PMID:
29436335
57. Masoori L, Falak R, Mokhtarian K, Bandehpour M, Razmjou E, Jalallou N, et al. Production of recombi-
nant 14-3-3 protein and determination of its immunogenicity for application in serodiagnosis of strongy-
loidiasis. Trans R Soc Trop Med Hyg. 2019:1–6. https://doi.org/10.1093/trstmh/try095
Application of FAR protein for immunodiagnosis of strongyloidiasis
PLOS ONE | https://doi.org/10.1371/journal.pone.0218895 July 22, 2019 15 / 15
